Halcygen Pharmaceuticals

Halcygen Pharmaceuticals (HGN)

Stock Code

HGN

Stock Exchange

ax

HalcyGen Pharmaceuticals Limited (HGN) is a company that focuses on testing and improvement of generic drugs. It was listed on ASX on 29 June, 2007. The company is currently developing two potential "SuperGenerics" which are SUBA-Itraconazole and Minocycline which have been licensed from Mayne. SuperGenerics aim to improve generic reference pharmaceuticals to create safer, more efficacious and/or easier to use pharmacies.

Halcygen Pharmaceuticals Dividends

18 October, 2010 - 00:53

Research the past dividends for Halcygen Pharmaceuticals. Dividends are a portion of company profits paid out to shareholders. If Halcygen Pharmaceuticals Limited has announced a dividend, you may be eligible to receive HGN dividends if the investor the company's shares on the ex-dividend date. In order to receive the dividend payout, investors must purchase the shares before the ex dividend date. The previous owner of the shares will receive the dividend if you buy the stocks on or after the ex dividend date.

Syndicate content

Recommended Websites